HIV Infections Clinical Trials

A listing of HIV Infections medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

Birmingham Alabama 35233

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Arizona

Phoenix Arizona 85015

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Arkansas

Little Rock Arkansas 72207

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

California

UPDATED

Los Angeles California 90232

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Los Angeles California 90073

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Los Angeles California 90035

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Los Angeles California 90033-1079

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Palm Springs California 92264

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

View More ▼

UPDATED

Palo Alto California 94304-5350

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

San Diego California 92103

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

San Francisco California 94110

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Torrance California 90502

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

Beverly Hills California 90211

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Long Beach California 90806

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Long Beach California 08275

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Los Angeles California 90069

A clinical trial to evaluate treatments using SB-728mR-HSPC Infusion 3 days following busulfan conditioning for patients with HIV

Los Angeles California 90054

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Los Angeles California 90095

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Los Angeles California 90033

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Los Angeles California 90036

Patients are needed to participate in a clinical research study evaluating MK-1439A for the treatment of HIV-1 Infection (MK-1439A-030)

Los Angeles California 90027

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Los Angeles California 90036

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Los Angeles California 90035

Patients are needed to participate in a clinical research study of Busulfan, Cal-1 modified HSPC and Cal-1 modified CD4+ T lymphocytes to evaluate Human Immunodeficiency Virus

Los Angeles California 90027

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Los Angeles California 90035

Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Rialto California 92377

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Sacramento California 95825

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Sacramento California 95811

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

San Diego California 92103

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

San Diego California 92103

Patients are needed to participate in a clinical research study evaluating ledipasvir and sofosbuvir and Placebo (for ledipasvir and sofosbuvir) for the treatment of Hepatitis C or Human Immunodeficiency Virus

San Francisco California 94115

A clinical research study of Therapeutic Conventional Surgery for the treatment of Anal Squamous Cell Carcinoma, HIV Infection, Stage 0 Anal Canal Cancer or Stage I Anal Canal Cancer

San Francisco California 94110

A clinical trial seeking patients for a research study for the treatment of HIV Infection

San Francisco California 94115

A clinical trial to evaluate treatments using SB-728mR-HSPC Infusion 3 days following busulfan conditioning for patients with HIV

San Francisco California 94117

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

San Francisco California 94118

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

San Francisco California 94115

Patients are needed to participate in a clinical research study of Busulfan, Cal-1 modified HSPC and Cal-1 modified CD4+ T lymphocytes to evaluate Human Immunodeficiency Virus

San Leandro California 94577

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Torrance California 90509

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Colorado

UPDATED

Aurora Colorado 80045

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

UPDATED

Denver Colorado 80204

A Phase 4 clinical study for patients with HIV Infections or Cardiovascular Diseases

Aurora Colorado 80045

A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating Directly Observed Therapy and Wirelessly Observed Therapy for the treatment of Hepatitis C or Virus, Human Immunodeficiency

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

View More ▼

Aurora Colorado 80045

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Denver Colorado 80205

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Denver Colorado 80209

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Lakewood Colorado 80228

A clinical trial to evaluate treatments using GSK1265744 30 mg for patients with Human Immunodeficiency Virus Infection

Lakewood Colorado 80228

A clinical trial to evaluate treatments using GSK1265744 30mg for patients with Infection, Human Immunodeficiency Virus